Search Results

Appendix 5 – PCR Testing (Procedure and Transportation).docx

Homely Remedies SOP (S16)

Under normal circumstances, medicines should be administered either on the written prescription of an authorised prescriber, in accordance with the Medicines Code or under the authority of a Patient Group Direction. The Medication Optimisation Safety Team (MOST) has approved a list of non-prescription medicines or “homely remedies” that registered nurses and registered practitioners are authorised to administer at their own discretion, in accordance with the attached standard operating procedure, for a maximum of 48 hours (extended to 72 hours over a bank holiday weekend). The homely remedies approved are treatments commonly available over the counter for minor, short-term conditions without the need for a prescription or Patient Group Direction.

Controlled Drugs SOP for Community Hospitals (S47)

This series of Standard Operating Procedures ensures that all processes involving Controlled Drugs (CDs) carried out in Wards and Departments of Community Hospitals are conducted in strict accordance with current statutory requirements that adequate records are maintained and a robust audit trail exists. This includes security, ordering, receipt, administration, issue, balance checking, and return or destruction.

Disclosure Ref 202219 - Roles and banding as at Jan 2022 - Copy.pdf

FOI Disclosure

HRP29 Registration Re-Registration and Revalidation Manager's Guide.docx

Appendix 10: Blood bikes information

Appendix 10: Blood bikes information, for clinicians - Section 5.28 Covid 19 IP&C Policy

High Risk - Diabetes Foot Care information and advice leaflet.pub

DCHS Declaraton - Staff Other Reg Prof.pdf

DCHS_Respectful Resolution - Allegation

Clinical Harms Review Additional detail for Service Level SOP (S133)

This document should be read in conjunction with the overarching DCHS Standard Operating procedure on Clinical Harms which outlines the processes to be followed to deliver a consistent approach to. • Risk stratification to minimise clinical harm as a result of delays in care. • Embedding systems which take into account health inequalities. • Monitoring waiting times against defined thresholds across pathways of care. • Delivering personalised, patient-centred communications to patients who are waiting for care. • Implementing Harm Reviews that support the Trusts governance and assurance processes and maintains practice in line with national expectations. The intention of the service level document is to provide specific detail on. • The risk stratification process in operation and clinically appropriate to specific service lines and patient cohorts • Waiting time thresholds for the relevant patient pathways